IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News

01/20

Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1191764202"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1191764202\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1191764202?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 14:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191764202","market":"sh","top_or_hot":-1,"title":"IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission","media":"Stock News","content":"<p>Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-01-20 14:50</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0142","symbol_name":"區塊鏈","start_time":0,"source_url":"","article_id":"1191764202","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191764202","pubTimestamp":1768891825,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300468":"四方精创","BK0142":"区块链","BK0231":"软件信息"},"translate_title":"IPO动态|深圳形成合创信息（300468.SZ）、臻趣科技拟赴港IPO申请获证监会受理","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91341":0.95,"300468":1},"content_text":"Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}